Equities

CareMax Inc

CMAX:NSQ

CareMax Inc

Actions
Health CareHealth Care Providers
  • Price (USD)2.93
  • Today's Change0.05 / 1.74%
  • Shares traded15.45k
  • 1 Year change-96.29%
  • Beta0.8438
Data delayed at least 15 minutes, as of May 31 2024 21:15 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CareMax, Inc. is a technology-enabled care platform providing value-based care and chronic disease management through physicians and health care professionals committed to the overall health and wellness continuum of care for its patients. It operates over 56 centers and managed affiliated providers across 10 states that offer a suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Its CareOptimize is an end-to-end technology platform that aggregates and analyzes data using proprietary algorithms and machine learning to support more informed care delivery decisions and to focus care decisions on preventative chronic disease management and the social determinants of health. The Company offers 24/7 access to care through employed providers and provides a comprehensive suite of high-touch health care and social services for its patients.

  • Revenue in USD (TTM)810.36m
  • Net income in USD-644.67m
  • Incorporated2020
  • Employees1.45k
  • Location
    CareMax Inc1000 Nw 57Th Court, Suite 400MIAMI 33126United StatesUSA
  • Phone+1 (305) 686-3912
  • Fax+1 (302) 636-5454
  • Websitehttps://www.caremax.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Selectis Health Inc36.67m-9.06m7.67m574.00------0.2091-2.96-2.9611.99-1.310.8309--15.6863,884.65-20.46-3.03-30.08-3.58-----24.63-4.84---3.361.12---9.4058.97-64.93---47.72--
Syra Health Corp6.08m-3.60m8.93m78.00--2.66--1.47-0.5946-0.59461.050.52241.77--10.1977,937.56-105.01---154.43--23.75---59.21-----83.830.0279---1.83---38.72------
Mangoceuticals Inc844.87k-9.02m9.77m--------11.56-0.492-0.4920.0455-0.04060.3826-------408.41---596.95--61.75---1,067.52--0.0622------8,082.22---361.07------
Pacific Health Care Organization Inc5.72m834.22k10.05m30.0012.060.913411.531.760.06510.06510.44590.85950.4725--6.09190,503.306.907.297.427.8179.4282.7514.6013.28----0.00---2.00-3.7055.80-10.80-15.93--
Caremax Inc810.36m-644.67m11.14m1.45k--0.5461--0.0138-172.31-172.31216.425.360.9467--6.07558,871.80-75.32---114.67---0.1988---79.55-----1.840.9506--19.01---1,707.99------
Medical Care Technologies Inc.0.00-1.07m11.23m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
Xcelerate Inc3.96m-296.19k12.11m1.00--8.70--3.06-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Aesthetic Medical Intl Hldg Grp Ltd(ADR)94.26m-5.17m12.42m1.29k--1.843.460.1318-0.1178-0.11782.210.14131.2316.6085.1473,297.39-7.21-23.36-44.53-48.5847.1855.32-5.85-23.720.2333-3.700.8791--1.86-2.1650.91--3.70--
Univec Inc-100.00bn-100.00bn12.87m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Clearday Inc7.54m-21.54m13.35m225.00------1.77-0.9722-0.99380.3147-1.700.3432--201.6333,524.13-77.04-71.37---342.36-----224.52-205.25---0.9413-----3.0594.7325.38---28.32--
NewGenIvf Group Ltd0.00-690.85k13.90m----0.3273-----0.1999-0.19990.004.190.00-------1.50---1.54--------------0.0944-------237.99------
Psychemedics Corp.21.60m-4.46m13.93m116.00--2.22--0.6452-0.773-0.7733.741.081.49--5.44186,172.40-30.68-7.44-46.72-9.7038.5737.55-20.64-6.26---184.940.0353---12.45-12.33-283.21---33.32--
PharmChem Inc6.04m722.90k13.94m170.0020.566.6919.282.310.14590.14591.220.44851.797.6210.04--21.47--25.28--65.12--11.96--3.98------3.50---16.95------
Healthlynked Corp4.97m-3.82m14.80m38.00--67.46--2.98-0.0142-0.01430.01850.00080.990713.4033.09130,827.90-76.20-119.37-189.55-332.2255.6655.81-76.92-119.260.6532--0.8047---2.3220.4357.08---12.94--
Data as of May 31 2024. Currency figures normalised to CareMax Inc's reporting currency: US Dollar USD

Institutional shareholders

39.27%Per cent of shares held by top holders
HolderShares% Held
Eminence Capital LPas of 31 Mar 2024353.65k9.30%
Morgan Stanley & Co. LLCas of 31 Mar 2024346.46k9.11%
Maverick Capital Ltd.as of 31 Mar 2024168.97k4.44%
BlackRock Fund Advisorsas of 31 Mar 2024149.93k3.94%
The Vanguard Group, Inc.as of 31 Mar 2024144.67k3.80%
Perceptive Advisors LLCas of 31 Mar 2024122.64k3.23%
Castleknight Management LPas of 31 Mar 202471.89k1.89%
Geode Capital Management LLCas of 31 Mar 202450.29k1.32%
SSgA Funds Management, Inc.as of 31 Mar 202445.83k1.21%
Triatomic Management LPas of 31 Mar 202439.12k1.03%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.